journal article·2024-05Open access

A New Polymeric Minimally Invasive Glaucoma Implant

Inês C.F. Pereira, Paul A.A. Bartels, Christian J.F. Bertens, Serge H.M. Söntjens, Hans M. Wyss, Albertus P.H.J. Schenning, Patricia Y.W. Dankers, Henny J.M. Beckers, Jaap M.J. den Toonder

Advanced Materials Technologies· Volume 9· Issue 9

Abstract

Abstract Glaucoma drainage devices are implanted in the eye to treat glaucoma, a disease that can cause vision loss and blindness. These devices are designed to reduce intraocular pressure (IOP), a major risk factor for the progression of glaucoma, by providing an alternative outflow path for the fluid produced by the eye, the aqueous humor. Here, a novel polymeric minimally invasive glaucoma implant designed to enhance aqueous humor outflow is demonstrated. The implant is made of a unique, potentially biodegradable thermoplastic material, polycarbonate bisamide (PC‐BA), and produced through replica molding using hot embossing and femtosecond laser‐machined glass molds. Post‐mortem experiments demonstrate successful device implantation into a rabbit's eye, with the implant remaining securely in place. Although the mass loss and changes in molecular weight observed in the in vitro degradation experiments are not significant within the tested times and degradation conditions, the PC‐BA is a slow‐degradation polymer that may take a few years to fully degrade. Thus, the implant will also slowly degrade and be absorbed by the body over time, leaving behind a natural outflow pathway. This potentially biodegradable glaucoma implant may represent a promising new approach for restoring outflow in a more natural way.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Glaucoma and retinal disorders · Retinal and Macular Surgery · Ocular Surface and Contact Lens

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Microsystems Research Section Department of Mechanical Engineering Eindhoven University of Technology P.O. Box 513 Eindhoven 5600 MB The Netherlands

Institute for Complex Molecular Systems (ICMS) Eindhoven University of Technology Den Dolech 2 Eindhoven 5600 MB The Netherlands

Laboratory of Chemical Biology Department of Biomedical Engineering Eindhoven University of Technology P.O. Box 513 Eindhoven 5600 MB The Netherlands

University Eye Clinic Maastricht Maastricht University Medical Centre+ (MUMC+) P. Debyelaan 25 Eindhoven 6229 HX The Netherlands

SyMO‐Chem BV Den Dolech 2 Eindhoven 5612 AZ The Netherlands

Stimuli‐Responsive Functional Materials & Devices Department of Chemical Engineering and Chemistry Eindhoven University of Technology Eindhoven 5600 MB The Netherlands

References (49)

Show source-provided references
1. 10.1038/s41598-020-69687-410.1038/s41598-020-69687-4 ↗
2. 10.1016/j.ophtha.2014.05.01310.1016/j.ophtha.2014.05.013 ↗
3. 10.1089/jop.2013.018510.1089/jop.2013.0185 ↗
4. 10.1016/j.survophthal.2019.08.00210.1016/j.survophthal.2019.08.002 ↗
5. 10.2147/OPTH.S29370210.2147/OPTH.S293702 ↗
6. 10.1111/ceo.1288810.1111/ceo.12888 ↗
7. 10.1016/j.ajo.2011.10.02610.1016/j.ajo.2011.10.026 ↗
8. 10.1016/j.ophtha.2016.06.03510.1016/j.ophtha.2016.06.035 ↗
9. 10.1016/j.ophtha.2014.08.04310.1016/j.ophtha.2014.08.043 ↗
10. 10.1016/j.ajo.2017.01.00310.1016/j.ajo.2017.01.003 ↗
11. 10.1007/s40123-018-0135-910.1007/s40123-018-0135-9 ↗
12. 10.5041/RMMJ.1034510.5041/RMMJ.10345 ↗
13. Richter G. M. · Clinical Ophthalmology · 2016 · 10 · 189
14. 10.1007/s40123-017-0098-210.1007/s40123-017-0098-2 ↗
15. 10.2147/OPTH.S13531610.2147/OPTH.S135316 ↗
16. 10.1001/archopht.1963.0096004078902210.1001/archopht.1963.00960040789022 ↗
17. 10.1038/s41433-021-01595-x10.1038/s41433-021-01595-x ↗
18. Sng C. C. A. · 2017
19. 10.1097/j.jcrs.000000000000032510.1097/j.jcrs.0000000000000325 ↗
20. 10.1007/s12325-021-02039-410.1007/s12325-021-02039-4 ↗
21. 10.1016/j.ophtha.2019.03.00610.1016/j.ophtha.2019.03.006 ↗
22. 10.1155/2020/875473010.1155/2020/8754730 ↗
23. 10.1097/IJG.000000000000180510.1097/IJG.0000000000001805 ↗
24. 10.1155/2016/105657310.1155/2016/1056573 ↗
25. 10.1097/OPX.000000000000117310.1097/OPX.0000000000001173 ↗
26. 10.3390/jcm1019441010.3390/jcm10194410 ↗
27. 10.1186/s40662-022-00294-210.1186/s40662-022-00294-2 ↗
28. 10.1097/IJG.000000000000096810.1097/IJG.0000000000000968 ↗
29. 10.1016/j.jcrs.2018.03.03010.1016/j.jcrs.2018.03.030 ↗
30. 10.1186/s40662-019-0154-110.1186/s40662-019-0154-1 ↗
31. 10.1080/17469899.2017.133559710.1080/17469899.2017.1335597 ↗
32. 10.1016/S0169-409X(03)00038-310.1016/S0169-409X(03)00038-3 ↗
33. Suthisomboon T. · 2020 · 1
34. 10.1002/latj.20180000310.1002/latj.201800003 ↗
35. 10.1039/c3lc50160d10.1039/c3lc50160d ↗
36. 10.1364/OE.18.02149010.1364/OE.18.021490 ↗
37. 10.2351/1.326311810.2351/1.3263118 ↗
38. D. S.Haffner H. K.Gille C. R.KalinaJr. J. J.Cogger System and Method for Delivering Multiple Ocular Implants 2019.
39. 10.3390/jfb804004410.3390/jfb8040044 ↗
40. 10.1089/ten.teb.2008.061910.1089/ten.teb.2008.0619 ↗
41. 10.1016/j.progpolymsci.2019.05.00410.1016/j.progpolymsci.2019.05.004 ↗
42. 10.3390/jdb401001110.3390/jdb4010011 ↗
43. 10.3390/pharmaceutics1412280610.3390/pharmaceutics14122806 ↗
44. 10.1002/adhm.20220106010.1002/adhm.202201060 ↗
45. 10.1016/j.actbio.2015.08.03410.1016/j.actbio.2015.08.034 ↗
46. 10.3389/fbioe.2019.0008710.3389/fbioe.2019.00087 ↗
47. 10.3389/fcvm.2022.88587310.3389/fcvm.2022.885873 ↗
48. Fea A. M. · Clinic. Ophthalmol. · 2014 · 8 · 875
49. 10.1016/j.ajo.2011.12.01710.1016/j.ajo.2011.12.017 ↗